SARS-CoV-2 Modulation of HIV Latency Reversal in a Myeloid Cell Line: Direct and Bystander Effects
Authors:
Open Access
Abstract
Coronavirus disease 2019 (COVID-19) might impact disease progression in people living with HIV (PLWH), including those on effective combination antiretroviral therapy (cART). These individuals often experience chronic conditions characterized by proviral latency or low-level viral replication in CD4+ memory T cells and tissue macrophages. Pro-inflammatory cytokines, such as TNF-α, IL-1β, IL-6, and IFN-γ, can reactivate provirus expression in both primary cells and cell lines. These cytokines are often elevated in individuals infected with SARS-CoV-2, the virus causing COVID-19. However, it is still unknown whether SARS-CoV-2 can modulate HIV reactivation in infected cells. Here, we report that exposure of the chronically HIV-1-infected myeloid cell line U1 to two different SARS-CoV-2 viral isolates (ancestral and BA.5) reversed its latent state after 24 h. We also observed that SARS-CoV-2 exposure of human primary monocyte-derived macrophages (MDM) initially drove their polarization towards an M1 phenotype, which shifted towards M2 over time. This effect was associated with soluble factors released during the initial M1 polarization phase that reactivated HIV production in U1 cells, like MDM stimulated with the TLR agonist resiquimod. Our study suggests that SARS-CoV-2-induced systemic inflammation and interaction with macrophages could influence proviral HIV-1 latency in myeloid cells in PLWH.Keywords
Funding Information
- Agencia Nacional de Promoción Científica y Tecnológica (ANPCyT) (PICTO-2021-00005-COVID, 2022NJYHMC)
- “Bando PRIN 2022” of the Italian Ministry of University and Research (PICTO-2021-00005-COVID, 2022NJYHMC)
This publication has 57 references indexed in Scilit:
- The abortive SARS‐CoV‐2 infection of osteoclast precursors promotes their differentiation into osteoclastsJournal of Medical Virology, 2024
- Immunogenic properties of SARS-CoV-2 inactivated by ultraviolet lightArchives of Virology, 2022
- Jurkat-Derived (J-Lat, J1.1, and Jurkat E4) and CEM-Derived T Cell Lines (8E5 and ACH-2) as Models of Reversible Proviral Latency2022
- U1 and OM10.1. Myeloid Cell Lines as Surrogate Models of Reversible Proviral Latency2022
- SARS‐CoV‐2 RNAemia with a higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID‐19Journal of Medical Virology, 2021
- Little to no expression of angiotensin‐converting enzyme‐2 on most human peripheral blood immune cells but highly expressed on tissue macrophagesCytometry Part A, 2020
- Frontline Science: COVID-19 infection induces readily detectable morphologic and inflammation-related phenotypic changes in peripheral blood monocytesJournal of Leukocyte Biology, 2020
- Effect of CSE on M1/M2 polarization in alveolar and peritoneal macrophages at different concentrations and exposure in vitroIn Vitro Cellular & Developmental Biology - Animal, 2020
- The lungs as anatomical reservoirs of HIV infectionReviews in Medical Virology, 2013
- Interleukin-6 and Glucocorticoids Synergistically Induce Human Immunodeficiency Virus Type-1 Expression in Chronically Infected U1 Cells by a Long Terminal Repeat Independent Post-Transcriptional MechanismMolecular Medicine, 2001